Following a consultation with its emergency task force, the European Medicines Agency (EMA) has backed a drug for adult patients with acute respiratory distress syndrome (ARDS) induced by the SARS‑CoV ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback